#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mantle cell lymphoma refractory PIK3CA related overgrowth spectrum Fibrosarcoma metastatic Subarachnoid haemorrhage Congenital disorder of glycosylation Primary mediastinal large B-cell lymphoma Oesophageal adenocarcinoma stage II Urethral valves Familial hypertriglyceridaemia Dementia Alzheimer's type Small intestine adenocarcinoma Prolymphocytic leukaemia Myeloid leukaemia Peripheral primitive neuroectodermal tumour of soft tissue Alexander disease More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Uterine leiomyosarcoma Chronic granulomatous disease – Treatment Stevens-Johnson syndrome – Trials in Disease Sjogren’s syndrome – Life with Disease Leukoencephalopathy – Trials in Disease Acute respiratory distress syndrome – Treatment Glycogen storage disease type I Cholangitis sclerosing Lymphatic malformation – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eculizumab [11C]Az14193391 Magnesium Hydroxide Cefoxitin Db-1303 Radotinib Dihydrochloride METHYLPHENIDATE PETHIDINE HYDROCHLORIDE Entinostat VHB937 Mitoxantrone NVG-2089 Pomalidomide Melphalan Hydrochloride Laronidase Idursulfase Cefazolin Op-1250 JX10 Pyrimethamine More therapies…

    Learn about Your Condition

    Ovarian cancer Hyperadrenocorticism Pneumonia Vascular malformation Abdominal wall pain Bacterial prostatitis Triple negative breast cancer Inflammatory bowel disease Rheumatic disorder Oesophageal cancer metastatic Guttate psoriasis Septic shock Suicidal ideation Embolic stroke Bipolar I disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Balcinrenone
    • Dapagliflozin
    Austria Bulgaria Czechia Finland France Germany +9

  • Study on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    • Venetoclax
    Austria Bulgaria Germany Italy Romania Spain

  • Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anhydrous Caffeine
    • Camphor
    • Dapirolizumab Pegol
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Crohn’s Disease: Evaluating Risankizumab’s Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Risankizumab
    Belgium Bulgaria Czechia France Germany Italy +4

  • Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • Aztreonam
    • Contezolid
    • Linezolid
    Bulgaria Croatia Czechia Estonia France Greece +9

  • Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

    Recruiting

    4 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Clazakizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Camizestrant
    • Exemestane
    Austria Belgium Bulgaria Czechia France Germany +8

  • Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Sodium Chloride
    Bulgaria Croatia Hungary Poland Romania

  • Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

    Recruiting

    3 1
    Investigated Drugs:
    • Telitacicept
    Belgium Bulgaria Czechia Denmark France Italy +2
Previous Page
1 … 5 6 7 8 9 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!